The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications
Open accessAbstract
Diabetes is a common metabolic illness characterized by hyperglycemia and is linked to long-term vascular problems that can impair the kidney, eyes, nerves, and blood vessels. By increasing protein glycation and gradually accumulating advanced glycation end products in the tissues, hyperglycemia plays a significant role in the pathogenesis of diabetic complications. Advanced glycation end products are heterogeneous molecules generated from non-enzymatic interactions of sugars with proteins, lipids, or nucleic acids via the glycation process. Protein glycation and the buildup of advanced glycation end products are important in the etiology of diabetes sequelae such as retinopathy, nephropathy, neuropathy, and atherosclerosis. Their contribution to diabetes complications occurs via a receptor-mediated signaling cascade or direct extracellular matrix destruction. According to recent research, the interaction of advanced glycation end products with their transmembrane receptor results in intracellular signaling, gene expression, the release of pro-inflammatory molecules, and the production of free radicals, all of which contribute to the pathology of diabetes complications. The primary aim of this paper was to discuss the chemical reactions and formation of advanced glycation end products, the interaction of advanced glycation end products with their receptor and downstream signaling cascade, and molecular mechanisms triggered by advanced glycation end products in the pathogenesis of both micro and macrovascular complications of diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890 · cited 1×
“It is associated with both acute and long-term vascular complications affecting the eye, kidney, nerves, and blood vessels which are the major causes of mortality and morbidity (Forbes and Cooper, 2013).”
BackgroundRole of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150 · cited 12×
“When AGE binds to receptors, it causes oxidative stress, nuclear factor (NF-κB) activation, and the synthesis of adhesive molecules and vascular cell adhesion molecules (VCAM-1), resulting in greater permeability of endothelial cells and a more intense invasion of lipids in the sub-endothelium (Milstone et al., 2016).”
BackgroundInfluentialAdvanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Nowotny, K., Jung, T., Höhn, A., Weber, D., & Grune, T. (2015) · Biomolecules · doi:10.3390/biom5010194 · Cited by 1,095 · cited 3×
“These cytokines, in turn, promote monocyte chemoattractant protein-1 (MCP-1) production in renal cells, which is related to monocyte/ macrophage infiltration into the cell (Nowotny et al., 2015).”
BackgroundInfluentialSivandzade, F., Prasad, S., Bhalerao, A., & Cucullo, L. (2019) · Redox Biology · doi:10.1016/j.redox.2018.11.017 · Cited by 639 · cited 1×
“NF-κB is a universal transcription factor normally found in an inactive form in the cytoplasm bound to its inhibitor protein called IκB (Sivandzade et al., 2019).”
BackgroundThe IκB kinase complex in NF‐κB regulation and beyond
Hinz, M., & Scheidereit, C. (2014) · The EMBO Reports · doi:10.1002/embr.201337983 · Cited by 572
Zhang, Q., Ames, J. M., Smith, R. D., Baynes, J. W., & Metz, T. O. (2009) · Journal of Proteome Research · doi:10.1021/pr800858h · Cited by 421 · cited 1×
“dehydration, oxidation, and other chemical events progressively degrade the Amadori product (keto-amine) to a variety of reactive carbonyl and dicarbonyl molecules such as glyoxal, methylglyoxal (MGO), and deoxyglucosones (Zhang et al., 2010; Tsekovska et al., 2016; Kim et al., 2017).”
BackgroundFishman, S. L., Sonmez, H., Basman, C., Singh, V., & Poretsky, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0060-3 · Cited by 330
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
Bongarzone, S., Savickas, V., Luzi, F., & Gee, A. D. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00058 · Cited by 313 · cited 2×
“Then NF-κB trans-locates to the nucleus and binds to a specific region of DNA, triggering the development of numerous cytokines, chemokines, cell adhesion molecules, interleukins, TGF, pro-inflammatory proteins, and proapoptotic genes (Huang and Hung, 2013; Hinz and Scheidereit, 2014; Suryavanshi and Kulkarni, 2017).”
BackgroundThe Role of Advanced Glycation End Products in Diabetic Vascular Complications
Rhee, S. Y., & Kim, Y. S. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.0105 · Cited by 274 · cited 1×
“Recently, both exogenous and endogenous AGEs have been implicated in the development of diabetic vascular problems in several investigations (Uribarri et al., 2015; Rhee and Kim, 2018).”
BackgroundGugliucci, A. (2017) · Advances in Nutrition · doi:10.3945/an.116.013912 · Cited by 225
Cited by
Proteomic Profiling of Plasma- and Gut-Derived Extracellular Vesicles in Obesity
Baptista Pereira, P., Torrejón, E., Ferreira, I., Carvalho, A. S., Teshima, A., Sousa-Lima, I., Beck, H. C., Costa-Silva, B., Matthiesen, R., Macedo, M. P., et al. (2024) · Nutrients · doi:10.3390/nu16050736 · Cited by 6
Metadata
- Authors
- Mengstie, M. A., Chekol Abebe, E., Behaile Teklemariam, A., Tilahun Mulu, A., Agidew, M. M., Teshome Azezew, M., Zewde, E. A., & Agegnehu Teshome, A.
- Venue
- Frontiers in Molecular Biosciences
- Publisher
- Frontiers Media SA
- Published
- 2022-09-15
- Volume
- 9
- Pages
- 1002710-1002710
- ISSN
- 2296-889X (ISSN-L)
- OpenAlex
- W4295925317
- Cited by
- 207
- References
- 14
- FWCI
- 18.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications. https://app.cochat.ai/papers/10.3389/fmolb.2022.1002710
- The paper
- Mengstie, M. A., Chekol Abebe, E., Behaile Teklemariam, A., Tilahun Mulu, A., Agidew, M. M., Teshome Azezew, M., Zewde, E. A., & Agegnehu Teshome, A. (2022). Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications. Frontiers in Molecular Biosciences. https://doi.org/10.3389/fmolb.2022.1002710
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.